Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 42, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 30 April 2025 - 14:35

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 42, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/dupixent

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters